Martin Shkreli
Martin Shkreli is a former hedge fund manager and pharmaceutical executive. In 2017, Shkreli was convicted of securities fraud and securities fraud conspiracy; in 2022, a federal court found him liable for an illegal Daraprim monopoly scheme and banned him from the pharmaceutical industry for life.